Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under FibroBiologics, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Leigh Steinberg, Director (Form 8-K filed 2026-08-24). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Hamid Khoja (filed 2026-09-17).
Who is behind it
FibroBiologics, Inc.: incorporated in Delaware; business address in Houston, Texas; industry Pharmaceutical Preparations (Form D, 2026-10-13).
Officers and directors, each with the role and the filing that names them:
- Pete O'Heeron: Executive Officer, Director (Form D, 2026-10-13)
- Richard C. Cilento: Director (Form D, 2026-10-13)
- Robert Hoffman: Director (Form D, 2026-10-13)
- Victoria Niklas: Director (Form D, 2026-10-13)
- Kathleen H. Rubins: Director (Form D, 2026-10-13)
- Leigh Steinberg: Director (Form D, 2026-10-13)
- Jason D. Davis: Executive Officer (Form D, 2026-10-13)
- Ruben A. Garcia: Executive Officer (Form D, 2026-10-13)
- Hamid Khoja: Executive Officer (Form D, 2026-10-13)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D, 2026-09-17 | Hamid Khoja | 7.5% |
| Schedule 13G, 2026-08-14 | Armistice Capital, LLC | 9.99% |
| Schedule 13G, 2026-04-09 | Lind Global Fund Iii LP | 4.99% |
| Schedule 13G/A, 2025-07-17 | Blackrock, Inc. | 2% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-24 | Leigh Steinberg | Director | appointed | 2026-08-20 |
| Form 8-K, 2026-07-09 | Kathleen Rubins | Director | appointed | 2026-07-08 |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2026-10-13 | $1.20M | $1.20M |
| Form D, 2026-09-16 | $500K | $500K |
| Form D, 2026-06-29 | $3M | $3M |
| Form D, 2025-12-16 | $1.73M | $1.73M |
| Form D, 2025-12-03 | $4M | $4M |
| Form D, 2025-12-03 | $1.50M | $1.50M |
Latest IPO step: FibroBiologics, Inc. filed its final IPO prospectus, ticker FBLG (424B4, 2026-04-01).
IPO filings: 424B4, 2026-04-01, S-1, 2026-03-27, S-1, 2025-12-23, 424B4, 2025-01-14, S-1/A, 2025-01-10; ticker FBLG on Nasdaq Capital Market.
Related pages
Funding and filing historyLeadership changes5%+ holdersCourt record
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/fibrobiologics-incLast updated 2026-10-18
Primary record: Schedule 13D, 2026-09-17 · Form D, 2026-10-13 · Form 8-K, 2026-08-24 · Form 8-K, 2026-07-09
Who owns FibroBiologics, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/fibrobiologics-inc